Ellis MJ - Search Results

1

Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.

Dowsett M, Ellis MJ, Dixon JM, Gluz O, Robertson J, Kates R, Suman VJ, Turnbull AK, Nitz U, Christgen M, Kreipe H, Kuemmel S, Bliss JM, Barry P, Johnston SR, Jacobs SA, Ma CX, Smith IE, Harbeck N. Dowsett M, et al. Among authors: ellis mj. NPJ Breast Cancer. 2020 Jun 8;6:21. doi: 10.1038/s41523-020-0168-9. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32550266 Free PMC article.

2

Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.

Buzdar AU, Come SE, Brodie A, Ellis M, Goss PE, Ingle JN, Johnston SR, Lee AV, Osborne CK, Vogel VG, Hart CS. Buzdar AU, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4335s-4337s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916221 Review. No abstract available.

3

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.

Robertson JF, Osborne CK, Howell A, Jones SE, Mauriac L, Ellis M, Kleeberg UR, Come SE, Vergote I, Gertler S, Buzdar A, Webster A, Morris C. Robertson JF, et al. Cancer. 2003 Jul 15;98(2):229-38. doi: 10.1002/cncr.11468. Cancer. 2003. PMID: 12872340 Free article. Clinical Trial.

4

Role of biologic markers in patient selection and application to disease prevention.

Dowsett M, Ellis MJ. Dowsett M, et al. Among authors: ellis mj. Am J Clin Oncol. 2003 Aug;26(4):S34-9. doi: 10.1097/00000421-200308001-00006. Am J Clin Oncol. 2003. PMID: 12902875

5

Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole.

Ellis MJ, Tao Y, Young O, White S, Proia AD, Murray J, Renshaw L, Faratian D, Thomas J, Dowsett M, Krause A, Evans DB, Miller WR, Dixon JM. Ellis MJ, et al. J Clin Oncol. 2006 Jul 1;24(19):3019-25. doi: 10.1200/JCO.2005.04.3034. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754938

6

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Ma CX, Ellis MJ. Ma CX, et al. Among authors: ellis mj. Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013. Semin Oncol. 2006. PMID: 17145344 Review.

7

A luminal breast cancer genome atlas: progress and barriers.

Ellis MJ, Dixon M, Dowsett M, Nagarajan R, Mardis E. Ellis MJ, et al. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):125-9. doi: 10.1016/j.jsbmb.2007.05.011. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17826627

8

Letrozole in the neoadjuvant setting: the P024 trial.

Ellis MJ, Ma C. Ellis MJ, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):33-43. doi: 10.1007/s10549-007-9701-x. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912634 Free PMC article. Clinical Trial.

9

Femara and the future: tailoring treatment and combination therapies with Femara.

Ellis M, Ma C. Ellis M, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):105-15. doi: 10.1007/s10549-007-9697-2. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912640 Free PMC article. Review.

10

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M. Ellis MJ, et al. J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23. J Natl Cancer Inst. 2008. PMID: 18812550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters